<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7569564/table_4" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 4</label>
  <p>Treatment, virus changes and outcomes of patients with COVID-19</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-."/>
   <th colspan="1" rowspan="1" id="0-1-.">All patients 
    <br/>( 
    <b>
     <i>N</i>
    </b> = 91) 
   </th>
   <th colspan="1" rowspan="1" id="0-2-.">Local cases 
    <br/>( 
    <b>
     <i>n</i>
    </b> = 35) 
   </th>
   <th colspan="1" rowspan="1" id="0-3-.">Imported cases ( 
    <b>
     <i>n =</i>
    </b> 56) 
   </th>
   <th colspan="1" rowspan="1" id="0-4-.">
    <b>
     <i>P</i>
    </b> value 
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td colspan="5">
    <b>Treatment</b>
   </td>
  </tr>
  <tr>
   <td> Chinese traditional medicine</td>
   <td>91 (100.0%)</td>
   <td>35 (100.0%)</td>
   <td>56 (100.0%)</td>
   <td>1.000</td>
  </tr>
  <tr>
   <td> Antiviral therapy</td>
   <td>89 (97.8%)</td>
   <td>33 (94.3%)</td>
   <td>56 (100.0%)</td>
   <td>0.112</td>
  </tr>
  <tr>
   <td> Oxygen therapy</td>
   <td>46 (50.5%)</td>
   <td>14 (40.0%)</td>
   <td>32 (57.1%)</td>
   <td>0.306</td>
  </tr>
  <tr>
   <td> Intravenous immunoglobulin therapy</td>
   <td>22 (24.2%)</td>
   <td>5 (14.3%)</td>
   <td>17 (30.4%)</td>
   <td>0.081</td>
  </tr>
  <tr>
   <td> Thymosin alpha1</td>
   <td>20 (22.0%)</td>
   <td>9 (25.7%)</td>
   <td>11 (19.6%)</td>
   <td>0.496</td>
  </tr>
  <tr>
   <td> Glucocorticoids</td>
   <td>13 (14.3%)</td>
   <td>3 (8.6%)</td>
   <td>10 (17.9%)</td>
   <td>0.218</td>
  </tr>
  <tr>
   <td> Intravenous antibiotic</td>
   <td>12 (13.2%)</td>
   <td>2 (5.7%)</td>
   <td>10 (17.9%)</td>
   <td>0.120</td>
  </tr>
  <tr>
   <td> Mechanical ventilation</td>
   <td>10 (11.0%)</td>
   <td>2 (5.7%)</td>
   <td>8 (14.3%)</td>
   <td>0.385</td>
  </tr>
  <tr>
   <td>  Non-invasive (i.e., face mask)</td>
   <td>1 (1.1%)</td>
   <td>1 (2.9%)</td>
   <td>0 (0.0%)</td>
   <td>0.145</td>
  </tr>
  <tr>
   <td>  Invasive</td>
   <td>9 (9.9%)</td>
   <td>1 (2.9%)</td>
   <td>8 (14.3%)</td>
   <td>0.385</td>
  </tr>
  <tr>
   <td>ECMO</td>
   <td>1 (1.1%)</td>
   <td>1 (2.9%)</td>
   <td>0 (0.0%)</td>
   <td>0.145</td>
  </tr>
  <tr>
   <td>Hospital stay, days, Median (IQR)</td>
   <td>14 (11–18)</td>
   <td>14 (11–17)</td>
   <td>15 (11–14)</td>
   <td>0.403</td>
  </tr>
  <tr>
   <td colspan="5">
    <b>Duration of SARS-CoV-2 RNA positivity from onset</b>
   </td>
  </tr>
  <tr>
   <td> Nasopharyngeal swabs, days</td>
   <td>11 (6–16)</td>
   <td>8 (5–16)</td>
   <td>12 (8–16)</td>
   <td>0.084</td>
  </tr>
  <tr>
   <td>  Median (IQR), [range]</td>
   <td>[1–39]</td>
   <td>[1–37]</td>
   <td>[4–39]</td>
   <td/>
  </tr>
  <tr>
   <td> Feces, days</td>
   <td>79/91, 13 (10–19)</td>
   <td>29/35, 13 (6–18)</td>
   <td>50/56, 13 (10–20)</td>
   <td>0.216</td>
  </tr>
  <tr>
   <td>  Median (IQR), [range]</td>
   <td>[1–40]</td>
   <td>[1–37]</td>
   <td>[4–40]</td>
   <td/>
  </tr>
  <tr>
   <td colspan="5">
    <b>Duration of SARS-CoV-2 shedding from onset</b>
   </td>
  </tr>
  <tr>
   <td> Nasopharyngeal swabs, days</td>
   <td>16 (13–23)</td>
   <td>15 (10–22)</td>
   <td>17 (14–23)</td>
   <td>0.148</td>
  </tr>
  <tr>
   <td>  Median (IQR), [range]</td>
   <td>[6–43]</td>
   <td>[8–37]</td>
   <td>[6–43]</td>
   <td/>
  </tr>
  <tr>
   <td> Feces (days)</td>
   <td>79/91, 19 (14–26)</td>
   <td>29/35, 18 (11–24)</td>
   <td>50/56, 19 (15–27)</td>
   <td>0.242</td>
  </tr>
  <tr>
   <td>  Median (IQR), [range]</td>
   <td>[6–43]</td>
   <td>[6–37]</td>
   <td>[8–43]</td>
   <td/>
  </tr>
  <tr>
   <td colspan="5">
    <b>Clinical outcome</b>
   </td>
  </tr>
  <tr>
   <td> Discharged</td>
   <td>88 (96.7%)</td>
   <td>34 (97.1%)</td>
   <td>54 (96.4%)</td>
   <td>1.000</td>
  </tr>
  <tr>
   <td> Died</td>
   <td>3 (3.3%)</td>
   <td>1 (1.1%)</td>
   <td>2 (3.6%)</td>
   <td>1.000</td>
  </tr>
 </tbody>
 <tfoot>
  <p>Data are 
   <i>n</i> (%) and mean (SD). 
   <i>N</i> is the total number of patients with available data. 
   <i>P</i> values for comparing two groups were derived using Fisher’s exact test for categorized variables and the 
   <i>t</i>-test for continuous variables 
  </p>
  <p>
   <i>COVID-19</i> Coronavirus disease-2019; 
   <i>SARS-CoV-2</i> Severe acute respiratory syndrome coronavirus 2; 
   <i>ECMO</i> Extracorporeal membrane oxygenation; 
   <i>NA</i> Not available; 
   <i>SD</i> Standard deviation; 
   <i>IQR</i> Interquartile range 
  </p>
 </tfoot>
</table>
